UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessing nutritional status in cancer: role of the Patient-Generated Subjective Global Assessment

Current opinion in clinical nutrition and metabolic care, 2017-09, Vol.20 (5), p.322-329

2017

Volltextzugriff (PDF)

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study

The Lancet (British edition), 2023-04, Vol.401 (10382), p.1091-1102

2023

Volltextzugriff (PDF)

Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial

Obstetrics and gynecology (New York. 1953), 2023-04, Vol.141 (4), p.737-747

2023

Volltextzugriff (PDF)

Totality of evidence refutes neoplasm risk with fezolinetant

The Lancet (British edition), 2024-05, Vol.403 (10440), p.1987-1988

2024

Volltextzugriff (PDF)

Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2)

Menopause (New York, N.Y.), 2024-04, Vol.31 (4), p.247-257

2024

Volltextzugriff (PDF)

Fezolinetant impact on health‐related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials

BJOG : an international journal of obstetrics and gynaecology, 2024-08, Vol.131 (9), p.1296-1305

2024

Volltextzugriff (PDF)

Treating moderate-to-severe menopausal vasomotor symptoms with fezolinetant: analysis of responders using pooled data from two phase 3 studies (SKYLIGHT 1 and 2)

Menopause (New York, N.Y.), 2024-06, Vol.31 (6), p.512

2024

Volltextzugriff (PDF)

Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause

Maturitas, 2024-08, Vol.186, p.107999, Article 107999

2024

Volltextzugriff (PDF)

Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast cancer

Cancer chemotherapy and pharmacology, 2021-12, Vol.88 (6), p.1033-1048

2021

Volltextzugriff (PDF)

Tri-country translation, cultural adaptation, and validity confirmation of the Scored Patient-Generated Subjective Global Assessment

Supportive care in cancer, 2019-09, Vol.27 (9), p.3499-3507

2019

Volltextzugriff (PDF)

Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy

Arthritis research & therapy, 2013-09, Vol.15 (5), p.R137-R137

2013

Volltextzugriff (PDF)

Long-term safety of pegloticase in chronic gout refractory to conventional treatment

Annals of the rheumatic diseases, 2013-09, Vol.72 (9), p.1469-1474

2013

Volltextzugriff (PDF)

Swedish translation and cultural adaptation of the scored Patient‐Generated Subjective Global Assessment (PG‐SGA©)—A validated tool for screening and assessing malnutrition in clinical practice and research

Scandinavian journal of caring sciences, 2024, Vol.38 (3), p.589-601

2024

Volltextzugriff (PDF)

Content validity across methods of malnutrition assessment in patients with cancer is limited

Journal of clinical epidemiology, 2016-08, Vol.76, p.125-136

2016

Volltextzugriff (PDF)

Correction to: Tri-country translation, cultural adaptation, and validity confirmation of the Scored Patient-Generated Subjective Global Assessment

Supportive care in cancer, 2021-11, Vol.29 (11), p.7127-7127

2021

Volltextzugriff (PDF)

A Japanese translation, cultural adaptation, and linguistic and content validity confirmation of the Scored Patient-Generated Subjective Global Assessment

Supportive care in cancer, 2021-12, Vol.29 (12), p.7329-7338

2021

Volltextzugriff (PDF)

Translation and Cultural Adaptation of the Scored Patient-Generated Subjective Global Assessment: An Interdisciplinary Nutritional Instrument Appropriate for Dutch Cancer Patients

Cancer nursing, 2018-11, Vol.41 (6), p.450-462

2018

Volltextzugriff (PDF)

Self‐Completion of the Patient‐Generated Subjective Global Assessment Short Form Is Feasible and Is Associated With Increased Awareness on Malnutrition Risk in Patients With Head and Neck Cancer

Nutrition in clinical practice, 2020-04, Vol.35 (2), p.353-362

2020

Volltextzugriff (PDF)

Clinical Significance of weight loss in cancer patients: Rationale for the use of anabolic agents in the treatment of cancer-related cachexia

Nutrition (Burbank, Los Angeles County, Calif.), 2001, Vol.17 (1), p.S1-S21

2001

Volltextzugriff (PDF)

Effect of pegloticase on renal function in patients with chronic kidney disease: a post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trials

BMC research notes, 2014-01, Vol.7 (1), p.54-54

2014

Volltextzugriff (PDF)

PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen®): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2019-04, Vol.33 (2), p.207-220

2019

Volltextzugriff (PDF)

Linguistic and content validation of the translated and culturally adapted PG-SGA, as perceived by Norwegian cancer patients and healthcare professionals

Clinical nutrition ESPEN, 2020-08, Vol.38, p.178-184

2020

Volltextzugriff (PDF)

Clinical nutrition ESPEN, 2022-02, Vol.47, p.215-220

2022

Volltextzugriff (PDF)

Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy

Journal of clinical rheumatology, 2014-12, Vol.20 (8), p.427-432

2014

Volltextzugriff (PDF)

Definition of standardized nutritional assessment and interventional pathways in oncology

Nutrition (Burbank, Los Angeles County, Calif.), 1996, Vol.12 (1), p.S15-S19

Ottery, Faith D.

1996

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(46)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Assessing nutritional status in cancer: role of the Patient-Generated Subjective Global Assessment

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study

Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial

Totality of evidence refutes neoplasm risk with fezolinetant

Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2)

Fezolinetant impact on health‐related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials

Treating moderate-to-severe menopausal vasomotor symptoms with fezolinetant: analysis of responders using pooled data from two phase 3 studies (SKYLIGHT 1 and 2)

Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause

Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast cancer

Tri-country translation, cultural adaptation, and validity confirmation of the Scored Patient-Generated Subjective Global Assessment

Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy

Long-term safety of pegloticase in chronic gout refractory to conventional treatment

Swedish translation and cultural adaptation of the scored Patient‐Generated Subjective Global Assessment (PG‐SGA©)—A validated tool for screening and assessing malnutrition in clinical practice and research

Content validity across methods of malnutrition assessment in patients with cancer is limited

Correction to: Tri-country translation, cultural adaptation, and validity confirmation of the Scored Patient-Generated Subjective Global Assessment

A Japanese translation, cultural adaptation, and linguistic and content validity confirmation of the Scored Patient-Generated Subjective Global Assessment

Translation and Cultural Adaptation of the Scored Patient-Generated Subjective Global Assessment: An Interdisciplinary Nutritional Instrument Appropriate for Dutch Cancer Patients

Self‐Completion of the Patient‐Generated Subjective Global Assessment Short Form Is Feasible and Is Associated With Increased Awareness on Malnutrition Risk in Patients With Head and Neck Cancer

Clinical Significance of weight loss in cancer patients: Rationale for the use of anabolic agents in the treatment of cancer-related cachexia

Effect of pegloticase on renal function in patients with chronic kidney disease: a post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trials

PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen®): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers

Linguistic and content validation of the translated and culturally adapted PG-SGA, as perceived by Norwegian cancer patients and healthcare professionals

Translation and cultural adaptation of the scored Patient-Generated Subjective Global Assessment (PG-SGA©)

Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy

Definition of standardized nutritional assessment and interventional pathways in oncology

Suchergebnisse filtern